Results 1 to 10 of about 15,738 (247)

Increased plasma DR‐70 (fibrinogen‐fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms [PDF]

open access: goldJournal of Veterinary Internal Medicine, 2023
Background Tumor biomarkers have used widely in clinical oncology in human medicine. Only a few studies have evaluated the clinical utility of tumor biomarkers for veterinary medicine.
Chiao‐Hsu Ke   +12 more
doaj   +2 more sources

Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19

open access: greenCurrent Drug Targets, 2022
Abstract:Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the highly patho-genic and highly transmissible human coronavirus that is the causative agent for the worldwide COVID-19 pandemic. COVID-19 manifests predominantly as a respiratory illness with symptoms consistent with viral pneumonia, but other organ systems (e.g., kidney, heart,
Matthew J. Flick   +2 more
openaire   +3 more sources

Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients

open access: goldChinese Medical Journal, 2015
Background: We investigated whether and to what extent the ratio between circulating fibrinogen (Fg) and its degradation products (FDP) reflects the severity of coronary artery disease (CAD) in type 2 diabetic patients.
Wei-Xin Xiong   +7 more
doaj   +2 more sources

Detection of fibrinogen-fibrin degradation products by counterelectrophoresis [PDF]

open access: bronzeJournal of Clinical Pathology, 1972
Counterelectrophoresis using a discontinuous buffer system permits detection of fibrinogen-fibrin degradation products (FDP) under a variety of clinical circumstances. The method is sensitive, reliable, and is easily performed using conventional equipment in any clinical laboratory assuming the responsibility for assaying fibrinogen-fibrin degradation ...
Jerome I. Brody
openaire   +4 more sources

Clarification of fibrin generation and degradation reaction processes of clot-fibrinolysis waveform in hemorrhagic disorders. [PDF]

open access: yesPLoS ONE
Clot-fibrinolysis waveform analysis (CFWA) is an assay used to simultaneously evaluate coagulation and fibrinolysis reactions. Although the assay detected the reaction via transmittance changes, there was no evidence that the transmittance changes ...
Tomoko Matsumoto   +9 more
doaj   +2 more sources

DR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms

open access: goldVeterinary Quarterly
Fibrinogen–fibrin degradation products (DR-70) are derived from tumor cells or metastases. Our previous study reported the diagnostic values in dogs with tumors, but no research has yet to be conducted to establish DR-70 as a prognostic marker.
Chiao-Hsu Ke   +11 more
doaj   +2 more sources

THE MECHANISM OF CLOTS FORMATION IN BLOOD PLASMA UNDER THE ACTION OF CHITIN DERIVATIVES [PDF]

open access: yesBiotechnologia Acta, 2019
The aim of the research was to find out the clot formation by the action of chitin derivates. The biochemical and immunologic investigation methods such as obtaining of fibrinogen, chitosan derivates, electrophoresis in PAAG, Western blot analysis, ELISE,
Spiridonov V.H.   +6 more
doaj   +1 more source

Characterization of the Components and Functional Properties of a Plasma-Derived Fibrin Sealant

open access: yesPlasmatology, 2023
Background The activity and purity of Fibrin Sealant Grifols are described in this article. This fibrin sealant contains two components (fibrinogen and thrombin) that mimic the final stages of clotting. Fibrin sealants are primarily used as an adjunct to
Ilaria Ramaiola   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy